182 related articles for article (PubMed ID: 25651905)
1. Emerging biologics for the treatment of chronic rhinosinusitis.
Pauwels B; Jonstam K; Bachert C
Expert Rev Clin Immunol; 2015 Mar; 11(3):349-61. PubMed ID: 25651905
[TBL] [Abstract][Full Text] [Related]
2. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
[TBL] [Abstract][Full Text] [Related]
3. Precision medicine in chronic rhinosinusitis - using endotype and endotype-driven therapeutic options.
Sima Y; Zhao Y; Wang X; Zhang L
Expert Rev Clin Immunol; 2023; 19(8):949-958. PubMed ID: 37387541
[TBL] [Abstract][Full Text] [Related]
4. Is there a future for biologics in the management of chronic rhinosinusitis?
Lam K; Kern RC; Luong A
Int Forum Allergy Rhinol; 2016 Sep; 6(9):935-42. PubMed ID: 27103607
[TBL] [Abstract][Full Text] [Related]
5. [Clinical treatment options oriented to the endotype of chronic rhinosinusitis].
Sima Y; Zhao Y; Jiao J; Wang X; Zhang L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Nov; 37(11):902-908. PubMed ID: 37905485
[No Abstract] [Full Text] [Related]
6. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.
Hellings PW; Alobid I; Anselmo-Lima WT; Bernal-Sprekelsen M; Bjermer L; Caulley L; Chaker A; Constantinidis J; Conti DM; De Corso E; Desrosiers M; Diamant Z; Gevaert P; Han JK; Heffler E; Hopkins C; Landis BN; Lourenco O; Lund V; Luong AU; Mullol J; Peters A; Philpott C; Reitsma S; Ryan D; Scadding G; Senior B; Tomazic PV; Toskala E; Van Zele T; Viskens AS; Wagenmann M; Fokkens WJ
Allergy; 2024 May; 79(5):1123-1133. PubMed ID: 38108602
[TBL] [Abstract][Full Text] [Related]
7. [The study and clinical application of the endotypes of chronic rhinosinusitis].
Sun L; Zhu D; Meng C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Aug; 34(8):765-768. PubMed ID: 32842216
[No Abstract] [Full Text] [Related]
8. A Decade of Pathogenesis Advances in Non-Type 2 Inflammatory Endotypes in Chronic Rhinosinusitis: 2012-2022.
Cui N; Zhu X; Zhao C; Meng C; Sha J; Zhu D
Int Arch Allergy Immunol; 2023; 184(12):1237-1253. PubMed ID: 37722364
[TBL] [Abstract][Full Text] [Related]
9. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.
Fokkens WJ; De Corso E; Backer V; Bernal-Sprekelsen M; Bjermer L; von Buchwald C; Chaker A; Diamant Z; Gevaert P; Han J; Hopkins C; Hox V; Klimek L; Lund VJ; Lee S; Luong A; Mullol J; Peters A; Pfaar O; Reitsma S; Toppila-Salmi S; Scadding GK; Sedaghat AR; Viskens AS; Wagenmann M; Hellings PW
Rhinology; 2024 Jun; 62(3):287-298. PubMed ID: 38217529
[TBL] [Abstract][Full Text] [Related]
10. [Research progress on internal classification and treatment response of chronic rhinosinusitis].
Yu L; Hu T
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 34(11):1049-1052. PubMed ID: 33254332
[No Abstract] [Full Text] [Related]
11. Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop.
Naclerio R; Baroody F; Bachert C; Bleier B; Borish L; Brittain E; Chupp G; Fisher A; Fokkens W; Gevaert P; Kennedy D; Kim J; Laidlaw TM; Lee JJ; Piccirillo JF; Pinto JM; Roland LT; Schleimer RP; Schlosser RJ; Schwaninger JM; Smith TL; Tan BK; Tan M; Toskala E; Wenzel S; Togias A
J Allergy Clin Immunol Pract; 2020 May; 8(5):1532-1549.e1. PubMed ID: 32142964
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
Okano M; Kanai K; Oka A
Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains.
La Mantia I; Ottaviano G; Ragusa M; Trimarchi M; Foglia E; Schettini F; Bellavia D; Cantone E
J Pers Med; 2024 Mar; 14(4):. PubMed ID: 38672974
[TBL] [Abstract][Full Text] [Related]
14. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis.
Bachert C; Zhang L; Gevaert P
J Allergy Clin Immunol; 2015 Dec; 136(6):1431-1440. PubMed ID: 26654192
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy for allergic diseases: at the intersection of cutting-edge science and clinical practice.
Boguniewicz M; Leung DY
J Allergy Clin Immunol; 2015 Feb; 135(2):354-6. PubMed ID: 25662304
[No Abstract] [Full Text] [Related]
16. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
Bachert C; Mannent L; Naclerio RM; Mullol J; Ferguson BJ; Gevaert P; Hellings P; Jiao L; Wang L; Evans RR; Pirozzi G; Graham NM; Swanson B; Hamilton JD; Radin A; Gandhi NA; Stahl N; Yancopoulos GD; Sutherland ER
JAMA; 2016 Feb; 315(5):469-79. PubMed ID: 26836729
[TBL] [Abstract][Full Text] [Related]
17. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps.
Bachert C; Gevaert P; Hellings P
J Allergy Clin Immunol Pract; 2017; 5(6):1512-1516. PubMed ID: 28526278
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal Antibodies for the Treatment of Nasal Polyps.
Willson TJ; Naclerio RM; Lee SE
Immunol Allergy Clin North Am; 2017 May; 37(2):357-367. PubMed ID: 28366482
[TBL] [Abstract][Full Text] [Related]
19. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
Rivero A; Liang J
Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
[TBL] [Abstract][Full Text] [Related]
20. Tailored therapy for severe asthma.
Menzella F; Lusuardi M; Galeone C; Zucchi L
Multidiscip Respir Med; 2015; 10(1):1. PubMed ID: 25671117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
